Hospitalization for severe COVID-19 more than doubles risk of MS, according to a study involving nearly 10 million people in ...

MS patients undergoing hematopoietic stem cell transplant (HSCT) face physical and emotional challenges at each treatment ...

Roche will acquire Poseida Therapeutics, building on a partnership for CAR T-cell therapies in development for MS and other ...

LPX-TI641, a therapy to promote immune system balance in MS and other autoimmune diseases, was assessed at varying doses in a ...

Higher levels of cholesterol in people with multiple sclerosis (MS) are associated with cognitive impairment, a study found.

Columnist Susan Payrovi finds that it takes a force of nature — namely, the dark and cold of approaching winter — to fortify ...

Columnist Desiree Lama, now a graduate student, explains why she never pursued academic accommodations to help her navigate ...

The FDA cleared an extended version of Neurophet AQUA that uses AI for analysis in counting and measuring MS brain lesions on ...

Fampyra (fampridine), which is approved to boost walking ability in adults with MS, may help people with poor working memory, ...

A large majority of RRMS patients experienced no evidence of disease activity for up to six years on Tysabri, a real-world ...

Physical therapy's benefits were seen without brain stimulation, but remained significant months later in those who got brain stimulation.

Columnist Benjamin Hofmeister is never thankful for having multiple sclerosis. But sometimes he's thankful for a change or two it's brought.